Cargando…

Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy

Introduction: HTX-019 (CINVANTI(®)) is a novel injectable emulsion formulation of the neurokinin 1 receptor antagonist (RA) aprepitant, approved for preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV). HTX-019 has demonstrated a tolerable safety profile when administered via...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navari, Rudolph M, Mosier, Michael C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503333/ https://www.ncbi.nlm.nih.gov/pubmed/31118678 http://dx.doi.org/10.2147/OTT.S201609

Ejemplares similares

Single‐dose NEPA versus an aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
por: Zelek, Laurent, et al.
Publicado: (2023)

Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection
por: Chakraborty, Abhijit, et al.
Publicado: (2009)

Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy
por: Navari, Rudolph M., et al.
Publicado: (2018)

Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
por: Hingmire, Sachin, et al.
Publicado: (2015)

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy
por: Chasen, Martin, et al.
Publicado: (2016)

Ultrafast 30‐min infusion of a rituximab biosimilar (Truxima)
por: Pérez‐Persona, Ernesto, et al.
Publicado: (2023)

Cost‐effectiveness of aprepitant in Japanese patients treated with cisplatin‐containing highly emetogenic chemotherapy
por: Tsukiyama, Ikuto, et al.
Publicado: (2018)

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
por: Zelek, Laurent, et al.
Publicado: (2021)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
por: Yoshida, Naohisa, et al.
Publicado: (2019)

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
por: Miya, Toshimichi, et al.
Publicado: (2016)

Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy
por: Toda, Haruka, et al.
Publicado: (2017)

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
por: Kang, Jin Hyoung, et al.
Publicado: (2020)

The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
por: Babu, Govind, et al.
Publicado: (2016)

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy
por: Tanioka, M, et al.
Publicado: (2013)

The mechanism of MinD stability modulation by MinE in Min protein dynamics
por: Carlquist, William C., et al.
Publicado: (2023)

The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy
por: Eghbali, Aziz, et al.
Publicado: (2023)

Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial
por: Eghbali, Aziz, et al.
Publicado: (2023)

Effects of 90- and 30-min naps or a 120-min nap on alertness and performance: reanalysis of an existing pilot study
por: Oriyama, Sanae
Publicado: (2023)

Cardiometabolic thresholds for peak 30-min cadence and steps/day
por: Adams, Bryan, et al.
Publicado: (2019)

Comparative evaluation of the effect of 10%, 20%, and 30% guava seed extract on reversing compromised resin bond strength after enamel bleaching in 120 min, 10 min, and 5 min: An in vitro study
por: Shahi, Mohnisha, et al.
Publicado: (2020)

MinÃ©ralogie /
por: Beudant, F. S. (Fran÷cois Sulpico), 1787-1850
Publicado: (1874)

MinIONQC: fast and simple quality control for MinION sequencing data
por: Lanfear, R, et al.
Publicado: (2019)

A plant MinD homologue rescues Escherichia coli HL1 mutant (ΔMinDE) in the absence of MinE
por: Zhang, Min, et al.
Publicado: (2009)

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study
por: Chang, Jianhua, et al.
Publicado: (2020)

Clinical Utility of 30-Min Postload Plasma Glucose in Paediatric Obesity
por: Poon, Sarah Wing-yiu, et al.
Publicado: (2021)

MinC, MinD, and MinE Drive Counter-oscillation of Early-Cell-Division Proteins Prior to Escherichia coli Septum Formation
por: Bisicchia, Paola, et al.
Publicado: (2013)

The decay of 33 min $^{104m}$Ag and 69 min $^{104g}$Ag
por: Münnich, F, et al.
Publicado: (1971)

The decay of 8 min $^{102m}$Ag and 13 min $^{102g}$Ag
por: Hnatowich, D J, et al.
Publicado: (1971)

MinE conformational switching confers robustness on self-organized Min protein patterns
por: Denk, Jonas, et al.
Publicado: (2018)

Resolving plasmid structures in Enterobacteriaceae using the MinION nanopore sequencer: assessment of MinION and MinION/Illumina hybrid data assembly approaches
por: George, Sophie, et al.
Publicado: (2017)

Geometry success in 20 mins
por: Editors, LearningExpress
Publicado: (2010)

Instant MinGW starter
por: Shpigor, Ilya
Publicado: (2013)

PSI (12+3min)
por: Seidel, Mike
Publicado: (2021)

IJCLab (12+3min)
por: Stocchi, Achille
Publicado: (2021)

Nikhef (12+3min)
por: Bentvelsen, Stan
Publicado: (2021)

Zo min mogelijk contact
por: Broersma, Simon
Publicado: (2020)

Direct MinE–membrane interaction contributes to the proper localization of MinDE in E. coli
por: Hsieh, Cheng-Wei, et al.
Publicado: (2010)

Membrane Binding of MinE Allows for a Comprehensive Description of Min-Protein Pattern Formation
por: Bonny, Mike, et al.
Publicado: (2013)

Corrigendum: Resolving plasmid structures in Enterobacteriaceae using the MinION nanopore sequencer: assessment of MinION and MinION/Illumina hybrid data assembly approaches
por: George, Sophie, et al.
Publicado: (2018)

Efficacy of small-volume simethicone given at least 30 min before gastroscopy
por: Song, Mingjun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4gch9aokq18elflbru16uikhdp